Novo Nordisk CSO Thomsen Assesses The Competition In Diabetes

 
• By Sten Stovall

The world of diabetes will increasingly be dominated by Novo Nordisk and Eli Lilly, the Danish group's chief science officer tells Scrip.

Mads Krogsgaard Thomsen
Mads Krogsgaard Thomsen Sees Eli Lilly As Main Rival To Novo Nordisk • Source: Shutterstock

More from Strategy

More from Business